Related references
Note: Only part of the references are listed.Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Guy Chouinard et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2017)
Withdrawal-Emergent Dyskinesia and Supersensitivity Psychosis Due to Olanzapine Use
Hakan Karas et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY (2016)
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Autism Spectrum Disorder
Fred Volkmar et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2014)
Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
Eun Ji Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
Shigenori Tadokoro et al.
SCHIZOPHRENIA BULLETIN (2012)
Anti psychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia - A systematic review
Keming Gao et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis
P Seeman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
